China NMPA Product Recall - Blood analyzer

The National Medical Products Administration (NMPA) issued an announcement on June 19, 2017, detailing a voluntary Class III recall initiated by Beckman Coulter Trading (China) Co., Ltd. This recall addresses specific blood analyzers, identified by Registration No.: 20142405955. The core issue prompting this action is the reported malfunction of these devices, which has the potential to produce incorrect classification results during blood analysis. Such inaccuracies in diagnostic testing can have significant implications for patient care and treatment decisions. In accordance with established regulatory frameworks overseen by the NMPA, Beckman Coulter Trading (China) Co., Ltd. is undertaking the required action of a voluntary recall to mitigate potential risks associated with the faulty products. Detailed information regarding the precise models, specifications, and batch numbers of the affected blood analyzers is provided in the 'Medical Device Recall Event Report Form,' which is made available alongside the NMPA's official publication. This proactive measure by Beckman Coulter Trading (China) Co., Ltd. demonstrates adherence to product quality and safety standards, emphasizing the importance of ensuring the reliability and accuracy of medical devices within the healthcare system, as mandated by the National Medical Products Administration.